Ameritas Investment Partners’s Assembly Biosciences ASMB Stock Holding History

Ameritas Investment Partners’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.6K	Buy	+895	New	+$24.4K	﹤0.01%	2646
2021 Q2	–	Sell	-206	Closed	-$11K	–	3056
2021 Q1	$11K	Hold	206	–	–	﹤0.01%	2799
2020 Q4	$15K	Hold	206	–	–	﹤0.01%	2603
2020 Q3	$41K	Hold	206	–	–	﹤0.01%	1949
2020 Q2	$58K	Buy	206 +34	+20%	+$7.93K	﹤0.01%	1740
2020 Q1	$31K	Buy	172 +31	+22%	+$6.64K	﹤0.01%	1922
2019 Q4	$35K	Hold	141	–	–	﹤0.01%	2108
2019 Q3	$17K	Hold	141	–	–	﹤0.01%	2465
2019 Q2	$23K	Hold	141	–	–	﹤0.01%	2361
2019 Q1	$33K	Hold	141	–	–	﹤0.01%	2099
2018 Q4	$38K	Hold	141	–	–	﹤0.01%	1964
2018 Q3	$63K	Buy	141 +26	+23%	+$12.2K	﹤0.01%	1855
2018 Q2	$54K	Hold	115	–	–	﹤0.01%	1941
2018 Q1	$68K	Buy	115 +12	+12%	+$7.44K	﹤0.01%	1734
2017 Q4	$56K	Hold	103	–	–	﹤0.01%	1865
2017 Q3	$33K	Hold	103	–	–	﹤0.01%	2125
2017 Q2	$25K	Buy	+103	New	+$29K	﹤0.01%	2327

Other funds holding ASMB

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Ameritas Investment Partners's ASMB Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 895 shares worth $24.6K. The stake represents ﹤0.01% of the portfolio and ranks #2646 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in ASMB as recently as Q1 2021.

Ameritas Investment Partners first reported a position in ASMB in Q2 2017 and has held it in 17 quarters since. The position peaked at $68K in Q1 2018. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

Ameritas Investment Partners held 895 shares of Assembly Biosciences worth $24.6K as of Q2 2026.
Assembly Biosciences was a new Ameritas Investment Partners position in Q2 2026.
Assembly Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2646 holding.
Ameritas Investment Partners first reported a position in Assembly Biosciences in Q2 2017 and has held it in 17 quarters since.
Ameritas Investment Partners's Assembly Biosciences position peaked at $68K in Q1 2018.
93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.